A M Kruisbeek

1.0k total citations
26 papers, 903 citations indexed

About

A M Kruisbeek is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, A M Kruisbeek has authored 26 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Genetics. Recurrent topics in A M Kruisbeek's work include T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (7 papers). A M Kruisbeek is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (7 papers). A M Kruisbeek collaborates with scholars based in United States, Netherlands and Italy. A M Kruisbeek's co-authors include Lisa Jones, Alicia M. Fry, Louis A. Matis, Barbara L. Rellahan, Alfred Singer, Patricia M. Andrysiak, Juan Carlos Zúñiga‐Pflücker, Dan L. Longo, S O Sharrow and Sandra H. Bridges and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

A M Kruisbeek

26 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A M Kruisbeek United States 17 750 151 131 120 69 26 903
M Taniguchi Japan 14 686 0.9× 105 0.7× 205 1.6× 146 1.2× 53 0.8× 33 836
H. Robson MacDonald Switzerland 16 941 1.3× 120 0.8× 225 1.7× 150 1.3× 108 1.6× 30 1.1k
R B Acres France 13 568 0.8× 147 1.0× 180 1.4× 267 2.2× 92 1.3× 20 848
O H Irigoyen United States 10 635 0.8× 315 2.1× 147 1.1× 92 0.8× 41 0.6× 15 857
Albertus D. Beyers United Kingdom 15 579 0.8× 169 1.1× 117 0.9× 238 2.0× 37 0.5× 19 886
E Eriksson United States 14 504 0.7× 76 0.5× 183 1.4× 96 0.8× 46 0.7× 16 651
E M Shevach United States 13 656 0.9× 113 0.7× 88 0.7× 131 1.1× 46 0.7× 20 809
Carole Kurahara United States 10 390 0.5× 91 0.6× 127 1.0× 180 1.5× 129 1.9× 12 682
M M Tutt United States 10 821 1.1× 119 0.8× 169 1.3× 117 1.0× 37 0.5× 10 924
Charles F. Scott United States 15 414 0.6× 162 1.1× 118 0.9× 265 2.2× 24 0.3× 24 756

Countries citing papers authored by A M Kruisbeek

Since Specialization
Citations

This map shows the geographic impact of A M Kruisbeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M Kruisbeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M Kruisbeek more than expected).

Fields of papers citing papers by A M Kruisbeek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A M Kruisbeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M Kruisbeek. The network helps show where A M Kruisbeek may publish in the future.

Co-authorship network of co-authors of A M Kruisbeek

This figure shows the co-authorship network connecting the top 25 collaborators of A M Kruisbeek. A scholar is included among the top collaborators of A M Kruisbeek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A M Kruisbeek. A M Kruisbeek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kruisbeek, A M, et al.. (1997). Nonresponsiveness and susceptibility to CTLA-4 of antigen-exposed CD4 T cells are not regulated by the Bcl-2 family of apoptotic mediators, but can be restored by IL-2.. PubMed. 24(4). 259–77. 1 indexed citations
2.
Izon, David J., et al.. (1996). Identification and functional analysis of Ly-6A/E as a thymic and bone marrow stromal antigen. The Journal of Immunology. 156(7). 2391–2399. 29 indexed citations
3.
Eynon, Elizabeth E., et al.. (1995). Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B. International Immunology. 7(7). 1065–1077. 26 indexed citations
4.
Jones, Lisa & A M Kruisbeek. (1992). What is the mechanism of induction of intrathymic tolerance?. Research in Immunology. 143(3). 291–294. 1 indexed citations
5.
Vos, Quirijn, Lisa Jones, & A M Kruisbeek. (1992). Mice deprived of exogenous antigenic stimulation develop a normal repertoire of functional T cells. The Journal of Immunology. 149(4). 1204–1210. 25 indexed citations
6.
Hsu, Victor W., Richard D. Klausner, J S Fine, A M Kruisbeek, & Michal Baniyash. (1992). Changes in the methylation pattern of the TCR zeta-chain gene correlate with its expression in T cells and developing thymocytes.. PubMed. 4(2). 166–71. 2 indexed citations
7.
Jones, Lisa, L. Thomas Chin, & A M Kruisbeek. (1991). Acquisition of self-tolerance in T cells is achieved by different mechanisms, operating both inside and outside the thymus.. PubMed. 16(3-4). 195–206. 10 indexed citations
8.
Rellahan, Barbara L., Lisa Jones, A M Kruisbeek, Alicia M. Fry, & Louis A. Matis. (1990). In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B.. The Journal of Experimental Medicine. 172(4). 1091–1100. 320 indexed citations
9.
10.
Takayama, Hajime, Guido Trenn, A M Kruisbeek, Osami Kanagawa, & Michail V. Sitkovsky. (1987). T cell antigen receptor triggered exocytosis in cytotoxic T lymphocytes is inhibited by soluble, but not immobilized monoclonal antibodies to Lyt-2 antigen.. The Journal of Immunology. 139(4). 1014–1021. 12 indexed citations
11.
Bridges, Sandra H., A M Kruisbeek, & Dan L. Longo. (1987). Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma.. The Journal of Immunology. 139(12). 4242–4249. 24 indexed citations
12.
13.
Aberer, Werner, A M Kruisbeek, Shinji Shimada, & S I Katz. (1986). In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.. The Journal of Immunology. 136(3). 830–836. 17 indexed citations
14.
Aberer, Werner, A M Kruisbeek, Satoru Shimada, & S I Katz. (1985). Modulation of antigen presenting cell function by in vitro administration of anti ia antibodies. Journal of Investigative Dermatology. 84(4). 355–356. 5 indexed citations
17.
Singer, Alfred, A M Kruisbeek, & Patricia M. Andrysiak. (1984). T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.. The Journal of Immunology. 132(5). 2199–2209. 91 indexed citations
18.
Morrissey, Philip, A M Kruisbeek, Susan O. Sharrow, & Alfred Singer. (1982). Tolerance of thymic cytotoxic T lymphocytes to allogeneic H-2 determinants encountered prethymically: evidence for expression of anti-H-2 receptors prior to entry into the thymus.. Proceedings of the National Academy of Sciences. 79(6). 2003–2007. 21 indexed citations
19.
Kruisbeek, A M, et al.. (1980). Alloreactive cytotoxic T lymphocytes from aged mice express increased lysis of autologous and third-party target cells.. The Journal of Immunology. 125(2). 858–864. 11 indexed citations
20.
Bekkum, D.W. van, et al.. (1977). Biologic activities of various thymus preparations.. PubMed. 9(1). 1197–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026